Literature DB >> 21850987

Primary cutaneous lymphomas: a reprisal.

Alessandro Pileri1, Annalisa Patrizi, Claudio Agostinelli, Iria Neri, Elena Sabattini, Francesco Bacci, Pier Paolo Piccaluga, Nicola Pimpinelli, Stefano A Pileri.   

Abstract

Primary cutaneous lymphomas (PCLs) are a group of lymphoid neoplasms provided with heterogeneous clinical, histological, immunohistochemical and molecular features. They can be classified in two groups: cutaneous T-cell lymphomas (CTCLs) and cutaneous B-cell lymphomas (CBCLs). Recent studies show an increase of the incidence of PCLs over the last three decades. Our aim is to evaluate the commonest types of PCL analysing the clinical characteristics, histology, phenotype, molecular biology, prognosis and therapy.

Entities:  

Mesh:

Year:  2011        PMID: 21850987     DOI: 10.1053/j.semdp.2011.04.002

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  3 in total

1.  Langerhans, plasmacytoid dendritic and myeloid-derived suppressor cell levels in mycosis fungoides vary according to the stage of the disease.

Authors:  Alessandro Pileri; Claudio Agostinelli; Maurizio Sessa; Pietro Quaglino; Marco Santucci; Carlo Tomasini; Vieri Grandi; Paolo Fava; Chiara Astrua; Simona Righi; Annalisa Patrizi; Stefano A Pileri; Nicola Pimpinelli
Journal:  Virchows Arch       Date:  2017-03-20       Impact factor: 4.064

2.  TG1042 (Adenovirus-interferon-γ) in primary cutaneous B-cell lymphomas: a phase II clinical trial.

Authors:  Brigitte Dreno; Mirjana Urosevic-Maiwald; Youn Kim; Joan Guitart; Madeleine Duvic; Olivier Dereure; Amir Khammari; Anne-Chantal Knol; Anna Derbij; Monika Lusky; Isabelle Didillon; Anne-Marie Santoni; Bruce Acres; Vincent Bataille; Marie-Pierre Chenard; Pascal Bleuzen; Jean-Marc Limacher; Reinhard Dummer
Journal:  PLoS One       Date:  2014-02-24       Impact factor: 3.240

3.  BCL-2 Expression in Primary Cutaneous Follicle Center B-Cell Lymphoma and Its Prognostic Role.

Authors:  Alessandro Pileri; Claudio Agostinelli; Clara Bertuzzi; Vieri Grandi; Vincenza Maio; Irene Lastrucci; Marco Santucci; Nicola Pimpinelli
Journal:  Front Oncol       Date:  2020-04-28       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.